Acusphere, Inc. (ACUS) Research

Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injectable suspension. Initially established as Polymers For Medicine, Inc., the organization rebranded as Acusphere, Inc. in March 2004. Founded in 1993, the company maintains its headquarters in Watertown, Massachusetts.

Market snapshot

Symbol
ACUS
Price
$0.00
Day change
0.00%
Market cap
$49.0
P/E ratio
-0.00x
52-week range
0.000001-0.00001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aequus Pharmaceuticals Inc. (AQSZF)
  • Black Bird Biotech, Inc. (BBBT)
  • Golden Developing Solutions, Inc. (DVLP)
  • IR Biosciences Holdings Inc. (IRBS)
  • MultiCorp International, Inc. (MCIC)
  • Neptune Wellness Solutions Inc. (NEPTF)
  • Nexien BioPharma, Inc. (NXEN)
  • Rimrock Gold Corp. (RMRK)

Recent insider activity

  • Gyenes Lawrence A — P-Purchase (51239 shares) on 2008-07-25
  • Gyenes Lawrence A — A-Award (200000 shares) on 2008-02-01
  • Gyenes Lawrence A — A-Award (200000 shares) on 2007-11-15
  • Gyenes Lawrence A — trade (0 shares) on 2007-10-01
  • THERO JOHN F — M-Exempt (70000 shares) on 2007-08-28

Open Acusphere, Inc. (ACUS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.